Source: India Times

New Delhi: Union Minister of State for Chemicals and Fertilizers, Mansukh Mandaviya said that the production of Hydroxychloroquine is more than the requirement in India, hence the government has lifted export restrictions on it.

“When the COVID crisis started we had two units making Hydroxychloroquine, now we have 12 and production is more than the requirement. Hence, the Government of India lifted export restrictions on it. Manufacturers have to sell 20 per cent in domestic market, the rest can be exported,”

Union Minister of State for Chemicals and Fertilizers, Mansukh Mandaviy

He shared that Hydroxychloroquine was banned when nationwide lockdown was announced earlier as at that time only two manufacturing units were producing 50 lakh tablets daily.

But today, 12 manufacturing units in the country are producing 1.5 crore tablets daily, he added.

“In such a situation, the Government of India has decided to lift the ban on Hydroxychloroquine, its APIs and formulations. All have to be sold 20 per cent in domestic market so that there is no shortage of medicine in the country,” Mandaviya stated and added that additional production can be exported in the global market.

Union Minister Sadananda Gowda had on Wednesday tweeted, “Department of Pharmaceuticals has approved the lifting of ban on Export of Hydroxychloroquine API as well as formulations. Manufacturers except SEZ/EOU Units have to supply 20 per cent production in the domestic market. DGFT has been asked to issue formal notification in this regard.”



Related: Hydroxychloroquine Market Size Worth Around US$ 6 Bn by 2027

Turkish company manufactures hydroxychloroquine drug

Syrian Labs Churn Out Anti-Malarial Drug

Manufacturer to move hydroxychloroquine production to the UK to avoid shortage

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

A Judge Stands up to a Hospital: “Step Aside” and Give a Dying Man Ivermectin

The judge’s finest moment may have been when he dashed the most glaring myth about ivermectin—that it is not safe, despite decades of use that shows otherwise. Noting that all drugs have side effects, Judge Fullerton listed ivermectin’s effects from a government website.
“(N)umber one, generally well tolerated; number two, dizziness; number three, pruritus; number four, nausea/diarrhea. These are the side effects for the dosage that’s being asked to be administered,” he said. “The risks of these side effects are so minimal that Mr. Ng’s current situation outweighs that risk by one-hundredfold.”

Read More »

How Dr. Paul Marik Saved a Grandmother & The World (Part 3)

Recently Merck issued a stern warning that seemed written by marketing, Kory says, “as it had no scientific data to support the conclusion,” that ivermectin was suddenly dangerous. Another pharmaceutical company’s CEO privately noted that “People must think Merck knows what they’re talking about because it’s their drug,” but Merck has “tremendous disincentives” to say nice things about the generic pill, as it has already spent hundreds of millions of dollars developing an oral anti-viral COVID-19 treatment, rival to ivermectin, that may be priced at $3,000 a dose.

Read More »

How Dr. Paul Marik Saved a Grandmother & The World (Part 2)

They also restricted the use of essential off-label and generic drugs with blatant disinformation campaigns that reminded Kory of big tobacco’s efforts to hide the dangers of smoking. In effect, the public health authorities eliminated the full toolbox of essential scientific methods and drugs that doctors use every day, including the most effective early, prophylactic, and late-stage treatments for COVID-19, which were developed by frontline doctors, not pharmaceutical companies.

Read More »

How Dr. Paul Marik Saved a Grandmother & The World (Part I)

In the professor’s continual review of “the latest (and best) literature,” he picked up a surprising “data signal” in October from emerging studies in Latin America. ivermectin, a safe, cheap, FDA-approved anti-parasitic drug, was showing remarkable anti-viral and anti-inflammatory activity as a repurposed drug—the most powerful COVID-19 killer known to science. 

Read More »